Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q19503

Entry ID Method Resolution Chain Position Source
AF-Q19503-F1 Predicted AlphaFoldDB

No variants for Q19503

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q19503

No associated diseases with Q19503

3 regional properties for Q19503

Type Name Position InterPro Accession
domain Homeobox domain 185 - 252 IPR001356
domain PBX, PBC domain 3 - 186 IPR005542
conserved_site Homeobox, conserved site 223 - 246 IPR017970

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

2 GO annotations of molecular function

Name Definition
DNA-binding transcription factor activity, RNA polymerase II-specific A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II.
RNA polymerase II cis-regulatory region sequence-specific DNA binding Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II.

4 GO annotations of biological process

Name Definition
animal organ morphogenesis Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
embryonic organ development Development, taking place during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
neuron development The process whose specific outcome is the progression of a neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.

7 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P40425 PBX2 Pre-B-cell leukemia transcription factor 2 Homo sapiens (Human) PR
P40424 PBX1 Pre-B-cell leukemia transcription factor 1 Homo sapiens (Human) PR
O35984 Pbx2 Pre-B-cell leukemia transcription factor 2 Mus musculus (Mouse) PR
Q75LX7 OSH10 Homeobox protein knotted-1-like 4 Oryza sativa subsp japonica (Rice) PR
Q75LX9 Os03g0673500 Putative homeobox protein knotted-1-like 5 Oryza sativa subsp japonica (Rice) PR
Q1PFD1 BLH11 BEL1-like homeodomain protein 11 Arabidopsis thaliana (Mouse-ear cress) PR
Q9SIW1 BLH7 BEL1-like homeodomain protein 7 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MSEASKSIMD LLSEVVKITD MTMDNEAVNK LKPQIKINPF YRAVQDVLVE QKSKIDLSTK
70 80 90 100 110 120
MMKDLEAQEN DERLDTMLKA EGVAGPDDSL LRIQEAAGTD QYEYRQQLLK VRRELENETK
130 140 150 160 170 180
AFDKHCKKWC EYVEDVLQQQ GEFRPITQQS TEKFMNKMSG KFNKVCFVLK QTACEEVIQL
190 200 210 220 230 240
KKRYLDARRK RRNFSKTSTE ILNEYFLANI NHPYPSEEVK QALAMQCNIS VAQVSNWFGN
250 260 270 280 290 300
KRIRYKKTMA KNEDERRENR KPEDRPPPGA PGAPYSLVPN AFAGMMNPYQ MMLPGHQFPI
310 320
GVAPFNFSMY NPEMMAQYQQ SLQNPNQTR